[ON BLOOD COAGULATION CHANGES AND THE ANTICOAGULANT  EFFECT OF MONOAMINE OXIDASE INHIBITORS].
D000925:Anticoagulants; D001777:Blood Coagulation; D004809:Ephedrine; D005017:Ethyl Biscoumacetate; D007020:Hypoprothrombinemias; D007490:Iproniazid; D008751:Methylene Blue; D008996:Monoamine Oxidase Inhibitors; D010600:Pharmacology; D011817:Rabbits; D051381:Rats; D012106:Research; D013923:Thromboembolism; D014191:Tranylcypromine
D000925:Anticoagulants; D008996:Monoamine Oxidase Inhibitors; D005017:Ethyl Biscoumacetate; D014191:Tranylcypromine; D007490:Iproniazid; D004809:Ephedrine; D008751:Methylene Blue
ANTICOAGULANTS; BLOOD COAGULATION; EPHEDRINE; ETHYL BISCOUMACETATE; EXPERIMENTAL LAB STUDY; HYPOPROTHROMBINEMIAS; IPRONIAZID; METHYLENE BLUE; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; RABBITS; RATS; THROMBOEMBOLISM; TRANYLCYPROMINE